Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

Blood (2024) 143 (17): 1738–1751.

https://doi.org/10.1182/blood.2023021952

Published: 2024

Includes: Supplemental data

Journal Articles

CNS Irradiation in Adult De Novo B-Precursor ALL / Lbl: Results of the Randomized GMALL T rial 08/2013 Indicate Potential Antileukemic Efficacy

Blood (2023) 142 (Supplement 1): 828.

https://doi.org/10.1182/blood-2023-179442

Published: 2023

Journal Articles

Expression of CD20 Affects Early MRD Response to Rituximab in Adult B Cell Precursor Lymphoblastic Leukemia of the GMALL 08/2013 Trial

Monika Szczepanowski, Johanna Richter, Miriam Kelm, Heiko Trautmann, Britta Kehden, Matthias Ritgen, Christoph Faul, Kathrin Nachtkamp, Björn Steffen, Andreas Viardot, Johannes Gärtner, Johannes Duell, Claudia D. Baldus, Stefan Schwartz, Nicola Goekbuget, Monika Brüggemann

Blood (2021) 138 (Supplement 1): 2301.

https://doi.org/10.1182/blood-2021-150375

Published: 2021

Journal Articles

Aberrant Cathepsin S Induces a Supportive Immune Microenvironment in Follicular Lymphoma

Blood (2019) 134 (Supplement_1): 657.

https://doi.org/10.1182/blood-2019-122663

Published: 2019

Journal Articles

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

Blood (2018) 132 (26): 2744–2753.

https://doi.org/10.1182/blood-2018-03-836932

Published: 2018

Includes: Supplemental data

Journal Articles

A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

Blood (2018) 132 (Supplement 1): 343.

https://doi.org/10.1182/blood-2018-99-112450

Published: 2018

Journal Articles

CD20 Expression and Response to Rituximab Treatment in B-Cell Precursor Lymphoblastic Leukemia - Results of the GMALL 08/2013 Trial

Monika Szczepanowski, PhD, Johanna Richter, Britta Kehden, Matthias Ritgen, MD, Heiko Trautmann, PhD, Henrik Knecht, PhD, Mustafa Kondakci, MD, Christoph Faul, MD, Björn Steffen, MD, Andreas Viardot, MD, Michael Kneba, Dieter Hoelzer, MD PhD, Nicola Goekbuget, MD, Monika Brüggemann

Blood (2018) 132 (Supplement 1): 1409.

https://doi.org/10.1182/blood-2018-99-114673

Published: 2018

Journal Articles

PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma

Verena Passerini, PhD, Michael Boesl, Elisabeth Silkenstedt, MD, Elisa Osterode, Michael Heide, Robert Kridel, PhD MD, Christoph Ziegenhain, Annette M. Staiger, PhD, German Ott, MD, Monika Szczepanowski, PhD, Julia Richter, PhD, Wolfram Klapper, MD, Andreas Rosenwald, Wolfgang Enard, PhD, Wolfgang Hiddemann, Deepak Bararia, PhD, Zimber-Strobl Ursula, Dr., Oliver Weigert, MD

Blood (2018) 132 (Supplement 1): 2842.

https://doi.org/10.1182/blood-2018-99-118063

Published: 2018

Journal Articles

Monitoring of the Clonal Architecture of B-Cell Precursor ALL during Induction Chemoimmunotherapy

Michaela Kotrova, MD PhD, Monika Szczepanowski, PhD, Henrik Knecht, PhD, Christoph Faul, MD, Mustafa Kondakci, MD, Björn Steffen, MD, Andreas Viardot, MD, Michael Kneba, Dieter Hoelzer, MD PhD, Nicola Goekbuget, MD, Nikos Darzentas, PhD, Monika Brüggemann

Blood (2018) 132 (Supplement 1): 1555.

https://doi.org/10.1182/blood-2018-99-112844

Published: 2018

Journal Articles

Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

Blood (2018) 132 (16): 1695–1702.

https://doi.org/10.1182/blood-2018-03-837252

Published: 2018

Includes: Supplemental data

Journal Articles

The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL)

Johannes Hellmuth, MD, Abner Louissaint, MD PhD, Monika Szczepanowski, PhD, Sarah Häbe, MD, Alessandro Pastore, MD, Annette M. Staiger, PhD, Sylvia Hartmann, Robert Kridel, Matthew D. Ducar, MS, Peter Koch, MD, Martin Dreyling, MD PhD, Martin-Leo Hansmann, MD, German Ott, MD, Andreas Rosenwald, MD, Randy D. Gascoyne, MD, David M. Weinstock, MD, Wolfgang Hiddemann, MD PhD, Wolfram Klapper, MD, Oliver Weigert, MD

Blood (2017) 130 (Supplement 1): 2735.

https://doi.org/10.1182/blood.V130.Suppl_1.2735.2735

Published: 2017

Journal Articles

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

Blood (2016) 128 (8): 1112–1120.

https://doi.org/10.1182/blood-2016-05-717355

Published: 2016

Includes: Supplemental data

Journal Articles

STAT6 Is Recurrently and Significantly Mutated in Follicular Lymphoma and Enhances the IL-4 Induced Expression of Membrane-Bound and Soluble CD23

Michael W Bösl, Elisa Osterode, Deepak Bararia, PhD, Alessandro Pastore, MD, Anette M Staiger, German Ott, MD, Monika Szczepanowski, PhD, Wolfram Klapper, MD, Andreas Rosenwald, MD, Wolfgang Hiddemann, MD, Oliver Weigert, MD

Blood (2015) 126 (23): 3923.

https://doi.org/10.1182/blood.V126.23.3923.3923

Published: 2015

Journal Articles

A Clinicogenetic Risk Model (m7-FLIPI) Prospectively Identifies One-Half of Patients with Early Disease Progression of Follicular Lymphoma after First-Line Immunochemotherapy

Blood (2015) 126 (23): 333.

https://doi.org/10.1182/blood.V126.23.333.333

Published: 2015

Journal Articles

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

Marius Rohde, Martin Zimmermann, Bettina R. Bonn, Monika Szczepanowski, Ilske Oschlies, Wolfram Klapper, MD, Anja Möricke, Martin Schrappe, Inga Nagel, Reiner Siebert, Alfred Reiter, MD, Birgit Burkhardt

Blood (2014) 124 (21): 2980.

https://doi.org/10.1182/blood.V124.21.2980.2980

Published: 2014

Journal Articles

Postranslationally Modified Proteins in the Central Nervous System (CNS) Are the Dominant Antigenic Target/Stimulus of the B-Cell Receptor (BCR) in Primary CNS Lymphomas (PCNSL) Providing Strong Evidence for the Role of Chronic Autoantigenic Stimulation As an Early Step in the Pathogenesis of Aggressive B-Cell Lymphomas

Lorenz Thurner, MD, Maria Kemele, Natalie Fadle, Evi Regitz, Patrick Roth, MD, Michael Weller, Prof., Monika Szczepanowski, Wolfram Klapper, Camelia-Maria Monoranu, MD, Andreas Rosenwald, MD, Rolf Buslei, MD, Rainer Maria Bohle, MD, Yoo-Jin Kim, MD, Klaus-Dieter Preuss, PhD, Michael Pfreundschuh

Blood (2014) 124 (21): 142.

https://doi.org/10.1182/blood.V124.21.142.142

Published: 2014

Journal Articles

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Blood (2014) 123 (8): 1187–1198.

https://doi.org/10.1182/blood-2013-06-507996

Published: 2014

Includes: Supplemental data

Journal Articles

Integrated Somatic Mutation and DNA Methylation Analysis Reveal Genomic and Epigenomic Co-Evolution In Follicular Lymphomas

Markus Loeffler, Prof MD PhD, Markus Kreuz, Andrea Haake, Dirk Hasenclever, PhD, Heiko Trautmann, PhD, Christian Arnold, Karsten Winter, Wolfram Klapper, René Scholtysik, Maciej Rosolowski, PhD, Steve Hoffmann, Ole Ammerpohl, Monika Szczepanowski, Dietrich Herrmann, Ralf Kueppers, Prof, Christiane Pott, M.D. Ph.D., Reiner Siebert, MD

Blood (2013) 122 (21): 502.

https://doi.org/10.1182/blood.V122.21.502.502

Published: 2013

Journal Articles

Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens

Neus Masqué-Soler, Monika Szczepanowski, Christian W. Kohler, Rainer Spang, Wolfram Klapper

Blood (2013) 122 (11): 1985–1986.

https://doi.org/10.1182/blood-2013-06-508937

Published: 2013

Includes: Supplemental data

Journal Articles

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

Wolfram Klapper, Markus Kreuz, Christian W. Kohler, Birgit Burkhardt, Monika Szczepanowski, Itziar Salaverria, Michael Hummel, Markus Loeffler, Shoji Pellissery, Wilhelm Woessmann, Carsten Schwänen, Lorenz Trümper, Swen Wessendorf, Rainer Spang, Dirk Hasenclever, Reiner Siebert, for the Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe

Blood (2012) 119 (8): 1882–1887.

https://doi.org/10.1182/blood-2011-10-388470

Published: 2012

Includes: Supplemental data

NARROW

CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment

CNS Irradiation in Adult De Novo B-Precursor ALL / Lbl: Results of the Randomized GMALL T rial 08/2013 Indicate Potential Antileukemic Efficacy

Expression of CD20 Affects Early MRD Response to Rituximab in Adult B Cell Precursor Lymphoblastic Leukemia of the GMALL 08/2013 Trial

Aberrant Cathepsin S Induces a Supportive Immune Microenvironment in Follicular Lymphoma

Hyper- N -glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphoma

A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

CD20 Expression and Response to Rituximab Treatment in B-Cell Precursor Lymphoblastic Leukemia - Results of the GMALL 08/2013 Trial

PARP14 Is a Novel Therapeutic Target in STAT6 mutant Follicular Lymphoma

Monitoring of the Clonal Architecture of B-Cell Precursor ALL during Induction Chemoimmunotherapy

Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles

The Mutational Landscape and Immune Microenvironment of Primary Intestinal Follicular Lymphoma (PIFL)

Clinicogenetic risk models predict early progression of follicular lymphoma after first-line immunochemotherapy

STAT6 Is Recurrently and Significantly Mutated in Follicular Lymphoma and Enhances the IL-4 Induced Expression of Membrane-Bound and Soluble CD23

A Clinicogenetic Risk Model (m7-FLIPI) Prospectively Identifies One-Half of Patients with Early Disease Progression of Follicular Lymphoma after First-Line Immunochemotherapy

New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Integrated Somatic Mutation and DNA Methylation Analysis Reveal Genomic and Epigenomic Co-Evolution In Follicular Lymphomas

Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens

Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only